A B O U T U S
An Integrated Platform for Innovation
Syngene is one of the largest integrated CRDMO players in India, operating at global scale with a one-stop platform for drug discovery, development and manufacturing.
Our capabilities span multiple modalities, including small molecules, peptides, biologics, antibody-drug conjugates (ADCs) and oligonucleotides. As a trusted partner, we work with large, mid-sized and emerging biopharma companies across the value chain, while also supporting customers in nutrition, animal health, consumer goods and specialty chemical industries. Our engagements extend to academic institutions, non-profit organizations, and government agencies. Flexible, customized partnership models range from specialist services to long-term strategic programs, aligned to customer priorities and ways of working.
Quality, technology and talent are central to how we deliver. Our fully digitized quality organization and strong compliance track record with global regulators support consistent execution, robust data integrity and reliable outcomes. We integrate artificial intelligence (AI) and machine learning (ML) capabilities across drug discovery workflows to support faster data analysis, improved decision-making and accelerated research timelines for clients. We continue to embed automation and digitization to strengthen efficiency, traceability and speed, while building scientific depth and cross-functional capability that enables long-term customer relationships rooted in trust, confidentiality and seamless collaboration.
Syngene is publicly listed on the Indian stock exchanges and is guided by a governance framework focused on transparency, accountability and long-term value creation. Along with business performance, we are strengthening responsible practices across operations and the value chain, with a focus on resource efficiency, safety and community outcomes in the regions where we operate.
Our Presence
Headquarters and main campus for research, development and manufacturing, Bengaluru, India
R&D Center, Genome Valley, Hyderabad, India
API manufacturing facility, Mangaluru, India
Bayview biologics manufacturing facility, Maryland, USA
USA commercial team
Commercial teams, United Kingdom and Europe
Map not to scale.For illustrative purposes only.
Business Divisions
Syngene operates through multiple business divisions: Discovery Services, Translational & Clinical Research, Dedicated Centers, and Contract Development and Manufacturing Services.
Our Discovery Services business offers a flexible platform with capabilities spanning a broad range of scientific approaches, including small and large molecules, peptides, oligonucleotides, ADCs and PROTACs. Within Discovery Biology and Biotherapeutics and Discovery Chemistry, we support customers across target identification, assay development, screening, hit-to-lead, lead optimization and candidate selection and IND-enabling packages including regulatory submissions.
This is supported by Syn.AI, our AI-enabled platform that supports data-driven research, predictive insights and accelerated decision-making across the drug discovery and development workflow.
T&CR business offers integrated early-phase clinical research services, spanning studies in healthy volunteers and patients. These capabilities are complemented by Clinical translational science, regulated bioanalysis across small and large molecules, along with Central Lab, Clinical Data Management and Biostatistics as allied services.
We also operate Dedicated Centers that provide ring-fenced infrastructure for exclusive operations for individual clients. These centers bring together dedicated multi-disciplinary teams of scientists, with access to the entire Syngene ecosystem for specialist research and development operations.
Our Small Molecule CDMO business supports customers across drug substance and drug product development, along with associated services to demonstrate the safety, tolerability and efficacy of selected drug candidates. Our capabilities include cGMP-compliant manufacturing of clinical supplies and registration batches, commercial supplies and access to a state-of-the-art API manufacturing facility.
Our Large Molecule CDMO business provides process development and manufacturing of clinical and commercial supplies, supported by associated services to demonstrate the safety, tolerability and efficacy of selected drug candidates. These capabilities are delivered through cGMP-compliant facilities and state-of-the-art biologics manufacturing infrastructure with an international presence.
Trusted by Global Leaders across Sectors
Note: This is a representative selection of the customers Syngene works with. All product names, logos, brands, trademarks and registered trademarks are the property of their respective owners.
